JIM
ACAD icon

Jupiter Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Jupiter Investment Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$51.1M Buy
1,054,941
+898,896
+576% +$43.2M 0.82% 32
2020
Q1 		$6.59M Buy
+156,045
New +$6.43M 0.13% 141

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jupiter Investment Management's ACAD Position: Q2 2020 in Review

Jupiter Investment Management increased its Acadia Pharmaceuticals (ACAD) stake by 576% in Q2 2020, buying an estimated $43.2M and bringing the position to 1,054,941 shares worth $51.1M. The position accounts for 0.82% of the portfolio, ranked #32.

Jupiter Investment Management first reported a position in ACAD in Q1 2020 and has held it in 2 quarters since. 297 funds tracked by Wall St. Rank hold ACAD as of Q2 2020.

  • Jupiter Investment Management held 1,054,941 shares of Acadia Pharmaceuticals worth $51.1M as of Q2 2020.
  • Jupiter Investment Management bought 898,896 Acadia Pharmaceuticals shares in Q2 2020, an estimated $43.2M.
  • Acadia Pharmaceuticals made up 0.82% of Jupiter Investment Management's portfolio in Q2 2020, its #32 holding.
  • Jupiter Investment Management first reported a position in Acadia Pharmaceuticals in Q1 2020 and has held it in 2 quarters since.
  • 297 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.